Popular Filters
Trials for Acute Myeloid Leukemia Patients
Antimetabolite
Chemotherapy + Stem Cell Transplant for Multiple Myeloma
Recruiting1 awardPhase 1
Duarte, California
This trial is studying the side effects and best dose of bortezomib when given together with fludarabine phosphate and melphalan with or without total marrow irradiation for patients with high-risk stage I or II multiple myeloma.
Anti-tumor antibiotic
Chemotherapy Combination for Leukemia
Recruiting3 awardsPhase 2
Houston, Texas
This trial is testing a combination of drugs to treat patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome. The drugs work in different ways to stop the growth of cancer cells.
Alkylating agents
Chemoradiotherapy + Stem Cell Transplant for Blood Cancers
Recruiting1 awardPhase 1 & 2
Duarte, California
This trial is giving chemotherapy drugs and HT before a donor stem cell transplant to see if it helps stop the growth of cancer cells and also helps stop the patient's immune system from rejecting the donor's stem cells.
Radiation Therapy
Intensity Modulated Total Marrow Irradiation + Fludarabine Phosphate + Melphalan for Hematologic Cancers
Recruiting1 awardPhase 1
Chicago, Illinois
This trial is testing IMTMI to see if it's less toxic and more effective than other types of radiation therapy when given with fludarabine and melphalan to patients with relapsed blood cancer before a stem cell transplant.
Trials for Acute Myelogenous Leukemia Patients
Antimetabolite
Chemotherapy + Stem Cell Transplant for Multiple Myeloma
Recruiting1 awardPhase 1
Duarte, California
This trial is studying the side effects and best dose of bortezomib when given together with fludarabine phosphate and melphalan with or without total marrow irradiation for patients with high-risk stage I or II multiple myeloma.
Alkylating agents
Chemoradiotherapy + Stem Cell Transplant for Blood Cancers
Recruiting1 awardPhase 1 & 2
Duarte, California
This trial is giving chemotherapy drugs and HT before a donor stem cell transplant to see if it helps stop the growth of cancer cells and also helps stop the patient's immune system from rejecting the donor's stem cells.
Radiation Therapy
Intensity Modulated Total Marrow Irradiation + Fludarabine Phosphate + Melphalan for Hematologic Cancers
Recruiting1 awardPhase 1
Chicago, Illinois
This trial is testing IMTMI to see if it's less toxic and more effective than other types of radiation therapy when given with fludarabine and melphalan to patients with relapsed blood cancer before a stem cell transplant.
Anti-metabolites
IM-TMI + Chemotherapy for AML and MDS
Recruiting1 awardPhase 2
Chicago, Illinois
This trial is testing whether adding a new kind of radiation to the standard myeloablative fludarabine/ i.v. targeted busulfan conditioning improves outcomes for patients receiving allogeneic hematopoietic stem cell transplant (HSCT).
Phase 3 Trials
Anti-metabolites
Chemotherapy for Pancreatic Cancer
Recruiting2 awardsPhase 3
Mobile, Alabama
This trial is studying gemcitabine hydrochloride given with or without erlotinib hydrochloride, followed by the same chemotherapy regimen with or without radiation therapy and capecitabine or fluorouracil, to see how well it works in treating patients with pancreatic cancer that has been removed by surgery.
Anti-metabolites
Ibrutinib + Rituximab for Chronic Lymphocytic Leukemia
Recruiting2 awardsPhase 3
Birmingham, Alabama
This trial is studying ibrutinib and rituximab compared to fludarabine phosphate, cyclophosphamide, and rituximab to see which works better in treating patients with untreated chronic lymphocytic leukemia or small lymphocytic lymphoma.
Anti-metabolites
5-Fluorouracil Injection for Chalazion
Recruiting4 awardsPhase 3
Seattle, Washington
This trial compares different treatments for eyelid lumps called chalazia. The treatments include medicine injections or minor surgery. The goal is to see which method best reduces or removes these lumps. Injections have been used effectively in treating chalazia, showing high success rates in previous studies.
Trials With No Placebo
Virus Therapy
LAIV for Flu
Recruiting1 awardPhase < 1
Birmingham, Alabama
This trial is testing the hypothesis that the T-bet expressing fraction of flu-specific B cells after receiving the live attenuated influenza vaccine (LAIV) serves as an early biomarker of long-lived antibody responses after vaccination.
Platinum-based Chemotherapy
Radiation Therapy + Fluorouracil for Rectal Cancer
Recruiting1 awardPhase 2
Concord, California
This trial tests if combining radiation therapy with chemotherapy can shrink tumors in patients with stage II or III rectal cancer. The treatment aims to make tumors smaller and easier to remove while protecting normal cells. The study will also look at the timing of treatments and their effects on surgery and recovery.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.